Overview

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Status:
Completed
Trial end date:
2016-08-23
Target enrollment:
Participant gender:
Summary
Test the safety, immune response and efficacy of GVAX pancreas vaccine (with cyclophosphamide) and CRS-207 compared to chemotherapy or CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Aduro Biotech, Inc.
Collaborator:
Johns Hopkins University
Treatments:
Capecitabine
Cyclophosphamide
Erlotinib Hydrochloride
Gemcitabine
Irinotecan
Pancreatin
Pancrelipase
Vaccines